These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 33726979)

  • 21. A novel diet-induced murine model of steatohepatitis with fibrosis for screening and evaluation of drug candidates for nonalcoholic steatohepatitis.
    Ejima C; Kuroda H; Ishizaki S
    Physiol Rep; 2016 Nov; 4(21):. PubMed ID: 27821715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of Hepatic Transcription Factor EB Attenuates Alcohol-Associated Liver Carcinogenesis.
    Chao X; Wang S; Hlobik M; Ballabio A; Ni HM; Ding WX
    Am J Pathol; 2022 Jan; 192(1):87-103. PubMed ID: 34717896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diethylnitrosamine-Induced Liver Tumorigenesis in Mice Under High-Hat High-Sucrose Diet: Stepwise High-Resolution Ultrasound Imaging and Histopathological Correlations.
    Cordier P; Sangouard F; Fang J; Kabore C; Desdouets C; Celton-Morizur S
    Methods Mol Biol; 2024; 2769():27-55. PubMed ID: 38315387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diethylnitrosamine enhances hepatic tumorigenic pathways in mice fed with high fat diet (Hfd).
    Arboatti AS; Lambertucci F; Sedlmeier MG; Pisani G; Monti J; Álvarez ML; Francés DEA; Ronco MT; Carnovale CE
    Chem Biol Interact; 2019 Apr; 303():70-78. PubMed ID: 30826251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Timp3 deficiency affects the progression of DEN-related hepatocellular carcinoma during diet-induced obesity in mice.
    Casagrande V; Mauriello A; Anemona L; Mavilio M; Iuliani G; De Angelis L; D'Onofrio M; Arisi I; Federici M; Menghini R
    Acta Diabetol; 2019 Dec; 56(12):1265-1274. PubMed ID: 31292722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of pemafibrate in nonalcoholic steatohepatitis model mice induced by a choline-deficient, high-fat diet and dextran sulfate sodium.
    Ota T; Soga K; Hayakawa F; Yamaguchi M; Tamano M
    Biochem Biophys Rep; 2024 Jul; 38():101724. PubMed ID: 38737727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lycopene metabolite, apo-10'-lycopenoic acid, inhibits diethylnitrosamine-initiated, high fat diet-promoted hepatic inflammation and tumorigenesis in mice.
    Ip BC; Hu KQ; Liu C; Smith DE; Obin MS; Ausman LM; Wang XD
    Cancer Prev Res (Phila); 2013 Dec; 6(12):1304-16. PubMed ID: 24085778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of elobixibat on liver tumors, microbiome, and bile acid levels in a mouse model of nonalcoholic steatohepatitis.
    Sugiyama Y; Yamamoto K; Honda T; Kato A; Muto H; Yokoyama S; Ito T; Imai N; Ishizu Y; Nakamura M; Asano T; Enomoto A; Zaitsu K; Ishigami M; Fujishiro M; Kawashima H
    Hepatol Int; 2023 Dec; 17(6):1378-1392. PubMed ID: 37666952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4
    Mossanen JC; Kohlhepp M; Wehr A; Krenkel O; Liepelt A; Roeth AA; Möckel D; Heymann F; Lammers T; Gassler N; Hermann J; Jankowski J; Neumann UP; Luedde T; Trautwein C; Tacke F
    Gastroenterology; 2019 May; 156(6):1877-1889.e4. PubMed ID: 30710528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Green tea extract inhibits early oncogenic responses in mice with nonalcoholic steatohepatitis.
    Dey P; Kim JB; Chitchumroonchokchai C; Li J; Sasaki GY; Olmstead BD; Stock KL; Thomas-Ahner JM; Clinton SK; Bruno RS
    Food Funct; 2019 Oct; 10(10):6351-6361. PubMed ID: 31503268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
    Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
    J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fatty acid elongation in non-alcoholic steatohepatitis and hepatocellular carcinoma.
    Kessler SM; Simon Y; Gemperlein K; Gianmoena K; Cadenas C; Zimmer V; Pokorny J; Barghash A; Helms V; van Rooijen N; Bohle RM; Lammert F; Hengstler JG; Mueller R; Haybaeck J; Kiemer AK
    Int J Mol Sci; 2014 Apr; 15(4):5762-73. PubMed ID: 24714086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Standardization of diethylnitrosamine-induced hepatocellular carcinoma rat model with time based molecular assessment.
    Ghufran H; Azam M; Mehmood A; Butt H; Riazuddin S
    Exp Mol Pathol; 2021 Dec; 123():104715. PubMed ID: 34699901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease.
    Ponziani FR; Bhoori S; Castelli C; Putignani L; Rivoltini L; Del Chierico F; Sanguinetti M; Morelli D; Paroni Sterbini F; Petito V; Reddel S; Calvani R; Camisaschi C; Picca A; Tuccitto A; Gasbarrini A; Pompili M; Mazzaferro V
    Hepatology; 2019 Jan; 69(1):107-120. PubMed ID: 29665135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diethylnitrosamine-induced liver tumorigenesis in mice.
    Schulien I; Hasselblatt P
    Methods Cell Biol; 2021; 163():137-152. PubMed ID: 33785162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early-Life Exposure to Low-Dose Cadmium Accelerates Diethylnitrosamine and Diet-Induced Liver Cancer.
    Men H; Young JL; Zhou W; Zhang H; Wang X; Xu J; Lin Q; Tan Y; Zheng Y; Cai L
    Oxid Med Cell Longev; 2021; 2021():1427787. PubMed ID: 34876963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel Animal Model of Nonalcoholic Steatohepatitis (NASH): Hypoxemia Enhances the Development of NASH.
    Takayama F; Egashira T; Kawasaki H; Mankura M; Nakamoto K; Okada S; Mori A
    J Clin Biochem Nutr; 2009 Nov; 45(3):335-40. PubMed ID: 19902025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. E2F1 and E2F2-Mediated Repression of CPT2 Establishes a Lipid-Rich Tumor-Promoting Environment.
    González-Romero F; Mestre D; Aurrekoetxea I; O'Rourke CJ; Andersen JB; Woodhoo A; Tamayo-Caro M; Varela-Rey M; Palomo-Irigoyen M; Gómez-Santos B; de Urturi DS; Núñez-García M; García-Rodríguez JL; Fernández-Ares L; Buqué X; Iglesias-Ara A; Bernales I; De Juan VG; Delgado TC; Goikoetxea-Usandizaga N; Lee R; Bhanot S; Delgado I; Perugorria MJ; Errazti G; Mosteiro L; Gaztambide S; Martinez de la Piscina I; Iruzubieta P; Crespo J; Banales JM; Martínez-Chantar ML; Castaño L; Zubiaga AM; Aspichueta P
    Cancer Res; 2021 Jun; 81(11):2874-2887. PubMed ID: 33771899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonalcoholic fatty liver disease and hepatocellular carcinoma.
    Zoller H; Tilg H
    Metabolism; 2016 Aug; 65(8):1151-60. PubMed ID: 26907206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Adenosine Monophosphate (AMP) Analog, 5-Aminoimidazole-4-Carboxamide Ribonucleotide (AICAR) Inhibits Hepatosteatosis and Liver Tumorigenesis in a High-Fat Diet Murine Model Treated with Diethylnitrosamine (DEN).
    Gao J; Xiong R; Xiong D; Zhao W; Zhang S; Yin T; Zhang X; Jiang G; Yin Z
    Med Sci Monit; 2018 Nov; 24():8533-8543. PubMed ID: 30474622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.